Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

Clinical trial NCT02949843 · TERMINATED

Trial details

NCT number: NCT02949843
Sponsor: Wake Forest University Health Sciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

EGFR Activating Mutation Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer

Start date: 2017-03-10
Primary completion: 2018-01-08
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.